CIDP (chronic inflammatory demyelinating polyneuropathy) trials in United States

In United States 20 Also abroad 43

20 trials · From ClinicalTrials.gov, checked 10 November 2026. Ask the study team whether a trial fits you.

Phase 3Taking people
A Study to Assess the Efficacy and Safety of Empasiprubart in Adults With CIDP
Where
Austin, Birmingham, Colorado Springs, Houston, Knoxville, Miami, Naples, Philadelphia, Rancho Mirage, Slidell, Tucson, Vero Beach, Washington D.C.
Age
18 years and over
People
160 worldwide
Run by
argenx
See details and how to joinNCT07091630 · EU 2025-520805-10-00
Phase 3Taking people
A Study Investigating Intravenous Human Normal Immune Globulin (IGIV) 10% KIg10 (QIVIGY) in Subjects With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
Where
El Paso, Lebanon, Miami, Pembroke Pines, Stamford, Tampa
Age
18 years and over
People
161
Run by
Kedrion S.p.A.
See details and how to joinNCT06752356
Phase 2/3Taking people
Efficacy and Safety Study of Nipocalimab for Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
Where
Augusta, Austin, Baltimore, Boston, Centennial, Charlotte, Cleveland, Coral Springs, Kansas City, Maitland, Miami, Milwaukee, New York, Patchogue, Royal Oak
Age
18 years and over
People
201 worldwide
Run by
Janssen Research & Development, LLC
See details and how to joinNCT05327114 · EU 2023-508425-28-00
Phase 2Taking people
A Study of TAK-411 in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
Where
Atlanta, Boston, Columbia, Jacksonville, La Jolla, Miami, Philadelphia, Raleigh, Rochester, Rockledge, San Francisco, Seattle, St Louis, Tampa, Washington D.C.
Age
18 years and over
People
36 worldwide
Run by
Takeda
See details and how to joinNCT06798012
Phase 3Taking people
A Study to Assess Efficacy and Safety of Empasiprubart Versus IVIg in Adults With CIDP
Where
Ann Arbor, Birmingham, Cincinnati, Colorado Springs, Columbia, Homestead, Houston, Irving, Knoxville, Miami, Nicholasville, Philadelphia, Rancho Mirage, Slidell, Tampa, Tucson, Washington D.C.
Age
18 years and over
People
218 worldwide
Run by
argenx
See details and how to joinNCT06920004 · EU 2024-520097-36-00
No phaseTaking people
Real-World Efgartigimod Effectiveness in CIDP: A Prospective Study
Where
Wilmington
Age
18 years and over
People
200 worldwide
Run by
argenx
See details and how to joinNCT07264426
Phase 3Taking people
A Study to Evaluate the Efficacy and Safety of DNTH103 in Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CAPTIVATE)
Where
Birmingham, Burlington, Chicago, Cincinnati, Columbus, Dallas, Denton, East Lansing, Edwardsville, Honolulu, Houston, Indianapolis, Kansas City, Lebanon, Los Angeles, Maitland, Nashville, New Haven, New York, Omaha, Phoenix, Portland, Round Rock, San Francisco, Scottsdale, Seattle, Sugar Land, Tampa, Washington D.C.
Age
18 years to 75 years
People
256 worldwide
Run by
Dianthus Therapeutics
See details and how to joinNCT06858579
Phase 1Taking people
A Study to Assess the Safety and Clinical Activity of Azer-cel in Participants With B-cell Mediated Autoimmune Disorders
Where
Ann Arbor, Cleveland, Columbus, La Jolla, Milwaukee, New York, Omaha, Rochester
Age
18 years and over
People
100
Run by
TG Therapeutics, Inc.
See details and how to joinNCT06680037
Phase 3Enrolling by invitation
Long-term Safety and Efficacy Study of Riliprubart in Participants With CIDP
Where
Homewood, Kansas City, New York, Philadelphia, Scottsdale
Age
18 years and over
People
300 worldwide
Run by
Sanofi
See details and how to joinNCT06859099 · EU 2024-517032-22-00
Phase 3Taking people
A Study to Test the Efficacy and Safety of Riliprubart Against the Usual Treatment of Intravenous Immunoglobulin (IVIg) in People With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
Where
Amherst, Austin, Baltimore, Beaumont, Boston, Bradenton, Burlington, Centennial, Charlottesville, Cincinnati, Cleveland, Detroit, East Lansing, Fairfield, Glenview, Hershey, Homewood, Houston, Kansas City, Lake Success, Las Vegas, Los Angeles, Miami Lakes, New Orleans, New York, Orange, Orlando, Philadelphia, Raleigh, Scottsdale, St Louis
Age
18 years and over
People
160 worldwide
Run by
Sanofi
See details and how to joinNCT06290141 · EU 2023-508338-33-00
Phase 1Taking people
Study of KITE-363 in Participants With Autoimmune Neurologic Diseases That Did Not Respond to Usual Treatment
Where
Newport Beach, New York, Palo Alto, Salt Lake City, Seattle
Age
18 years to 75 years
People
57 worldwide
Run by
Kite, A Gilead Company
See details and how to joinNCT07304154
Phase 3Taking people
A Study to Evaluate the Pharmacokinetics and Safety of XEMBIFY Versus Gamunex-C in Participants With Chronic Inflammatory Demyelinating Polyradiculoneuropathy
Where
Coral Springs, Cordova, Fayetteville, Houston, Miami, New York, Port Charlotte, Rancho Mirage, Sherman
Age
18 years and over
People
40 worldwide
Run by
Grifols Therapeutics LLC
See details and how to joinNCT07540221
Phase 2Taking people
Imeroprubart in Adult Participants With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
Where
Boston, Canton, Carlsbad, Chapel Hill, Charlotte, Chicago, Detroit, Houston, Kansas City, Las Vegas, Maitland, Miami, Milwaukee, Mission Hills, New Haven, New York, Nicholasville, Orange, Ormond Beach, Parker, Philadelphia, Port Charlotte, Portland, Rancho Mirage, Rockledge, San Antonio, San Francisco, Tucson, Washington D.C., Worcester, Yukon
Age
18 years and over
People
162 worldwide
Run by
Immunovant Sciences GmbH
See details and how to joinNCT07032662 · EU 2024-517614-14-00
Phase 3Taking people
Study to Evaluate Safety and Efficacy of Different PANZYGA Dose Regimens in Pediatric Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) Patients
Where
Birmingham, Charlottesville, Houston, Louisville, Orange, Philadelphia
Age
2 years to 17 years
People
30
Run by
Octapharma
See details and how to joinNCT04929236
No phaseTaking people
Real-world Study of Treatment Outcomes in Chronic Inflammatory Demyelinating Polyneuropathy/Polyradiculoneuropathy (CIDP)
Where
Swiftwater
Age
18 years and over
People
200
Run by
Sanofi
See details and how to joinNCT06968975
Phase 4Taking people
Two Dose Levels of Privigen in Pediatric CIDP
Where
Akron, Flower Mound, Iowa City, Los Angeles, Memphis, Norfolk, Philadelphia, Phoenix, Seattle
Age
2 years to 17 years
People
30
Run by
CSL Behring
See details and how to joinNCT03684018
No phaseTaking people
A Worldwide Pregnancy Safety Study to Assess Maternal, Fetal, and Infant Outcomes Following Exposure to Efgartigimod During Pregnancy and/or Breastfeeding.
Where
Morgantown
People
279 worldwide
Run by
argenx
See details and how to joinNCT06299748
Phase 3Taking people
A Study to Compare TAK-881 and HYQVIA in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
Where
Burlington, Chapel Hill, Cleveland, Denton, Durham, Greenfield, Maitland, New Haven, New York, Palo Alto, Portland, Raleigh, Rockledge, Scottsdale, St Louis, Winston-Salem
Age
18 years and over
People
59 worldwide
Run by
Takeda
See details and how to joinNCT06747351 · EU 2024-517450-95-00
Phase 1Taking people
IVIG vs SCIG in CIDP
Where
New Brunswick
Age
18 years to 65 years
People
20
Run by
Rutgers, The State University of New Jersey
See details and how to joinNCT05584631
No phaseTaking people
A Study of HyQvia in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) in Routine Clinical Care
Where
Bradenton, Honolulu, Kansas City, New Haven, O'Fallon, Rancho Mirage, San Francisco, St. Petersburg, Winston-Salem
Age
18 years and over
People
30 worldwide
Run by
Takeda
See details and how to joinNCT06538064 · EU 2024-512690-26-00